Valuation Crossject Börse Stuttgart
Stocks
74C
FR0011716265
Medical Equipment, Supplies & Distribution
|
Market Closed -
Börse Stuttgart
15:57:03 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 1.302 EUR | -2.98% |
|
-2.25% | -39.16% |
| 09-25 | Crossject: H126. Quid novi sub sole? Not much. | AL |
| 09-25 | Crossject Société Anonyme Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Company Valuation: Crossject
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 78.44 | 99.04 | 189 | 104.5 | 115.5 | 71.32 | - | - |
| Change | - | 26.25% | 90.83% | -44.71% | 10.53% | -38.25% | - | - |
| Enterprise Value (EV) 1 | 88.99 | 105.4 | 205.6 | 118.5 | 115.5 | 53.42 | 24.32 | -11.08 |
| Change | - | 18.43% | 95.08% | -42.35% | -2.56% | -53.75% | -54.47% | -145.55% |
| P/E | -6.95x | -11x | -21.6x | -7.93x | -11.5x | 3.2x | 2.52x | 1.82x |
| PBR | -13.4x | 44.6x | -35.7x | -49.2x | - | 2.38x | 1.28x | 0.82x |
| PEG | - | 0.4x | 0.9x | -0.4x | 0.4x | -0x | 0.1x | 0x |
| Capitalization / Revenue | 86x | 104x | 14.7x | 7.88x | 7.76x | 1.17x | 1.09x | 0.91x |
| EV / Revenue | 97.6x | 110x | 16x | 8.94x | 7.76x | 0.88x | 0.37x | -0.14x |
| EV / EBITDA | -12.1x | -15.2x | -33.6x | -14.6x | - | 1.31x | 0.52x | -0.19x |
| EV / EBIT | -7.53x | -7.93x | -16.7x | -9.14x | -9.95x | 1.41x | 0.56x | -0.21x |
| EV / FCF | - | - | -16.3x | -10.3x | -10.6x | 2.25x | 0.75x | -0.28x |
| FCF Yield | - | - | -6.13% | -9.69% | -9.39% | 44.4% | 134% | -352% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.41 | -0.3 | -0.23 | -0.28 | -0.19 | 0.41 | 0.52 | 0.72 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 0.912 | 0.954 | 12.83 | 13.26 | 14.88 | 60.8 | 65.2 | 78.3 |
| EBITDA 1 | -7.333 | -6.93 | -6.115 | -8.115 | - | 40.8 | 46.7 | 57 |
| EBIT 1 | -11.82 | -13.29 | -12.3 | -12.96 | -11.61 | 37.8 | 43.5 | 53 |
| Net income 1 | - | - | -8.467 | -12.8 | -10.37 | 28.3 | 35.6 | 48.1 |
| Net Debt 1 | 10.55 | 6.356 | 16.62 | 14.03 | - | -17.9 | -47 | -82.4 |
| Reference price 2 | 2.850 | 3.295 | 4.970 | 2.220 | 2.190 | 1.310 | 1.310 | 1.310 |
| Nbr of stocks (in thousands) | 27,523 | 30,057 | 38,026 | 47,070 | 52,740 | 54,444 | - | - |
| Announcement Date | 3/24/22 | 3/20/23 | 4/2/24 | 3/27/25 | 3/25/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 27.63x | 3.84x | 14.83x | 2.64% | 169B | |
| 18.25x | 3.37x | 12.04x | 3.26% | 110B | |
| 21.42x | 4.21x | 14.72x | 1.31% | 106B | |
| 25.26x | 2.48x | 10.04x | 2.86% | 73.87B | |
| 16.92x | 0.2x | 12.42x | 0.77% | 58.98B | |
| 29.48x | 7.29x | 18.84x | 1.36% | 51.28B | |
| 34.07x | 3.32x | 11.38x | 2.22% | 48.16B | |
| 35.11x | 8.73x | 24.55x | -.--% | 40.84B | |
| 34.3x | 6.01x | 18.87x | -.--% | 32.21B | |
| Average | 26.94x | 4.38x | 15.30x | 1.6% | 76.69B | |
| Weighted average by Cap. | 25.35x | 3.98x | 14.47x | 1.99% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ALCJ Stock
- 74C Stock
- Valuation Crossject
Select your edition
All financial news and data tailored to specific country editions
